The global pharmaceutical industry is going through a significant shift in the way it operates. Dr Stefanie Lietsch-Dallwig, senior director global program management - service solution lead Local Affiliate Services, at PharmaLex shares her insights on how this shift will impact the local affiliate model in an Expert View piece.
Globalization of the pharmaceutical industry has brought both opportunities and challenges. On one hand, this brings new and wider revenue streams. However, there is also a need to develop careful strategies to manage a strict, complex and often vastly differing global regulatory landscape.
Despite some efforts to harmonize, there remain different approaches to drug and device regulation from region to region in areas as wide ranging as safety, quality, administration and technology.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze